Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AngioDynamics, Inc. - Common Stock (NQ:ANGO)

11.07 -0.15 (-1.34%)
Streaming Delayed Price Updated: 11:19 AM EST, Feb 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about AngioDynamics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
AngioDynamics to Report Fiscal 2026 First Quarter Results on October 2, 2025
From AngioDynamics, Inc.
Via Business Wire
News headline image
Recent Report Shows That Rep. Debbie Wasserman Schultz Bought Up to $15K Worth of Ichor Holdings Stock ↗
 
Via Benzinga
News headline image
AngioDynamics to Present at the Canaccord Genuity 45th Annual Growth Conference
From AngioDynamics, Inc.
Via Business Wire
News headline image
A Congress Member Sold Up To $30K In AngioDynamics Stock: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Earnings Outlook For AngioDynamics ↗
 
Via Benzinga
News headline image
AngioDynamics Enrolls First Patient in AMBITION BTK Trial Advancing Treatment for Critical Limb Ischemia
From AngioDynamics, Inc.
Via Business Wire
News headline image
AngioDynamics Announces Publication of PRESERVE Study of NanoKnife® System for Prostate Tissue Ablation in European Urology
From AngioDynamics, Inc.
Via Business Wire
News headline image
Why AngioDynamics Stock Popped, Then Dropped Today ↗
AngioDynamics' big Q4 earnings beat wasn't as impressive as it first seemed. 
Via The Motley Fool
Topics Earnings
News headline image
AngioDynamics 'Exceptionally Well-Positioned' For 2026, CEO Says: But Tariffs Still Sting ↗
AngioDynamics expects a $4 million-$6 million impact from tariffs. Still, it's "profitable," CEO Jim Clemmer says. 
Via Benzinga
Topics World Trade
News headline image
AngioDynamics (ANGO) Q4 2025 Earnings Transcript ↗
Via The Motley Fool
Topics World Trade
News headline image
AngioDynamics Reports Strong Fiscal Year 2025 Fourth Quarter and Full Year Financial Results; Continued Execution Driving Accelerated, Profitable Growth
From AngioDynamics, Inc.
Via Business Wire
News headline image
Earnings Scheduled For July 15, 2025 ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
Get insights into the top gainers and losers of Monday's after-hours session. ↗
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. 
Via Chartmill
News headline image
AngioDynamics to Report Fiscal 2025 Fourth Quarter and Full-Year Financial Results on Tuesday, July 15, 2025
From AngioDynamics, Inc.
Via Business Wire
News headline image
AngioDynamics Announces First Patient Enrolled in RECOVER-AV Clinical Trial Evaluating AlphaVac F1885 System for Treatment of Acute Pulmonary Embolism
From AngioDynamics, Inc.
Via Business Wire
News headline image
Gold Moves Higher; US Private Sector Job Growth Tops Estimates ↗
 
Via Benzinga
News headline image
Traders are paying attention to the gapping stocks in Wednesday's session. ↗
In today's session, there are notable price gaps in the US markets on Wednesday. Take a closer look at the stocks that are gap up and gap down. 
Via Chartmill
News headline image
Medical Device Maker AngioDynamics Stock Jumps On Better Than Expected Q3 Earnings, Upbeat Annual Guidance ↗
AngioDynamics raised its fiscal 2025 sales outlook to $285M-$288M and boosted its adjusted EBITDA forecast, expecting stronger Med Tech revenue growth. 
Via Benzinga
News headline image
These stocks are moving in today's pre-market session ↗
The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today. 
Via Chartmill
News headline image
Cognyte Software Posts Upbeat Results, Joins AngioDynamics, Allegiant Travel And Other Big Stocks Moving Higher On Wednesday ↗
 
Via Benzinga
News headline image
AngioDynamics Stock Rockets On Upbeat Q3, Improved Full-Year Guidance – But Retail Sentiment Plummets ↗
The medical technology company now expects net sales to be $285 to $288 million for the fiscal year 2025, up from previously issued guidance of $282 to $288 million, owing to increased medical... 
Via Stocktwits
News headline image
AngioDynamics Reports Fiscal Year 2025 Third Quarter Financial Results
From AngioDynamics, Inc.
Via Business Wire
News headline image
Earnings Scheduled For April 2, 2025 ↗
 
Via Benzinga
News headline image
Uncovering Potential: AngioDynamics's Earnings Preview ↗
 
Via Benzinga
News headline image
AngioDynamics to Host Virtual Cardiovascular Investor Event
From AngioDynamics, Inc.
Via Business Wire
News headline image
AngioDynamics to Report Fiscal 2025 Third Quarter Financial Results on April 2, 2025 and Host Virtual Cardiovascular Investor Event
From AngioDynamics, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
UiPath Posts Weak Revenue, Joins SentinelOne, American Eagle And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
AngioDynamics to Present at the Oppenheimer 35th Annual Healthcare MedTech and Services Virtual Conference
From AngioDynamics, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.